Recognized by Explore affordable backed GLP-1 treatments, guided by licensed providers and built for real results
The Phase 2b trial used subcutaneous injection, not oral formulation
Months 2+ Sustained appetite and metabolic regulation With a re-established microbiome and consistently supported GLP-1 signalling, appetite control becomes more automatic less reliance on willpower, fewer unplanned snacks, more comfortable at appropriate meal sizes
Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium
For people with diabetes, too much sugar is already in the blood
More studies are being done to learn about its long-term effects, but the current research is promising